Drug Discovery Outsourcing Market-Global Industry Analysis and forecast (2022 – 2029)


Drug Discovery Outsourcing Market size is expected to reach US$ 5.89 Bn. by year 2029 at a CAGR of 7.4% during the forecast period.

Drug Discovery Outsourcing Market

To know about the Research Methodology :- Request Free Sample Report

The report has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.

Drug discovery outsourcing is the procedure which is used to find novel drugs or medicines in different fields such as pharmacology, biotechnology and pharmaceuticals. Drug discovery is a time-intense process and the success rate of the discovery is very low. Various new and small players in the industry who develop drugs and sell them to the big players so that they can scrutinize after the trials and identify whether the drugs are valuable or not.

The MMR report covers all the trends and technologies playing a major role in the growth of the drug discovery outsourcing market over the forecast period. The trend for reformative medicine is gaining popularity because of the efficacy of these medicines. This is hopeful governments to assign funds and grants to increase research in product advance and regenerative drug. Pharmaceutical key players are outsourcing drug detection for regenerative medicines to reduce costs and enhancement efficiency.

Technological development in silico drug designing and accelerating integration of AI in drug detection is playing a dynamic role in the industry progress. Many applications of AI algorithms in drug discovery and design offer opportunities for players to provide specialized drug discovery facilities. It is useful for procedures like predictive analytics, screening, compound selection, and drug repurposing.

North America drug discovery outsourcing market was valued US$ xx Mn. in 2021 and is expected to reach a value of US$ xx Mn. by 2029, with a CAGR of 60% during the forecast period. The high R&D activities thanks to the rising need of the effective drugs have caused the drug discovery outsourcing market growth. Additionally, the progress of research organizations has also contributed to the drug discovery outsourcing market growth.

On the other hand, APAC is expected to register a remarkable market growth. The supportive government enterprises and growing outsourcing activities by the medium scale and small scales companies have led the drug discovery outsourcing market growth in Asia.

The MMR report will also provide an accurate analysis of the contribution of the various segments to the growth of the drug discovery outsourcing market. By therapeutic area, the respiratory system segment expected to grow at the highest 35% CAGR during the forecast period. Higher acceptance of drug discovery outsourcing, coupled with a well-established product collection resulting from outsourcing, is accountable for the high revenue in the market.

By drug type, small molecules segment is expected to grow at a high growth of xx% CAGR during the forecast period. This is attributed to the manufacturing of small molecules is easy and can be manufactured in big amounts with negligible errors.

Major players in the drug discovery outsourcing market have taken several strategic measures, such as facility expansions and partnerships. As in Feb 2020, Charles River Laboratories International Company acquired Citoxlab for USD 510 Mn. Citoxlab is a non-clinical CRO corporation that focuses on regulated safety valuation services, medical device testing and no regulated discovery services.

The objective of the report is to present a comprehensive analysis of the Global Drug Discovery Outsourcing Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Drug Discovery Outsourcing Market dynamics, structure by analyzing the market segments and projects the Global Drug Discovery Outsourcing Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Drug Discovery Outsourcing Market make the report investor’s guide.

Drug Discovery Outsourcing Market Scope : Inquire before buying


Drug Discovery Outsourcing Market, by Workflow

• Target Identification & Screening
• Target Validation & Functional Informatics
• Lead Identification & Candidate Optimization
• Preclinical Development
• Other Associated Workflow

Drug Discovery Outsourcing Market, by Therapeutic Area

• Respiratory System
• Pain and Anesthesia
• Oncology
• Ophthalmology
• Hematology
• Cardiovascular
• Endocrine
• Gastrointestinal
• Immunomodulation
• Anti-Infective
• Central Nervous System
• Dermatology
• Genitourinary System

Drug Discovery Outsourcing Market, by Drug Type

• Small Molecules
• Large Molecules (Biopharmaceuticals)

Drug Discovery Outsourcing Market, by Region

• North America
o USA
o Canada
• Europe
o UK
o France
o Germany
o Italy
o Spain
o Norway
o Russia
• Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o Malaysia
o Indonesia
o Vietnam
• South America
o Mexico
o Brazil
o Argentina
• Middle East and Africa
o GCC Countries
o South Africa
o Nigeria
o Egypt

Drug Discovery Outsourcing Market Key players

• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
• WuXi AppTec Co., Ltd.
• Albany Molecular Research Inc. (AMRI)
• GVK Biosciences Private Limited
• Sygnature Discovery
• Pharmaron Beijing Co., Ltd
• WuXi Biologics (Cayman), Inc.
• Domainex Ltd.
• Thermo Fisher Scientific, Inc.
• Jubilant Biosys Ltd.
• Evotec SE
• Eurofins Discovery,
• GenScript Biotech Corporation
• Asclepia MedChem Solutions
• Asinex Ltd.
• AsisChem Inc.
• Aurelia Bioscience Ltd
• Axxam SpA
• Selcia Ltd
• Selvita S.A.

Frequently Asked Questions:

1. Which region has the largest share in Global Drug Discovery Outsourcing Market?
Ans: North America region holds the highest share in 2021.

2. What is the growth rate of Global Drug Discovery Outsourcing Market?
Ans: The Global Drug Discovery Outsourcing Market is growing at a CAGR of 7.4% during forecasting period 2022-2029.

3. What is scope of the Global Drug Discovery Outsourcing market report?
Ans: Global Drug Discovery Outsourcing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Drug Discovery Outsourcing market?
Ans: The important key players in the Global Drug Discovery Outsourcing Market are – CHARLES RIVER LABORATORIES INTERNATIONAL, INC., WuXi AppTec Co., Ltd., Albany Molecular Research Inc. (AMRI), GVK Biosciences Private Limited, Sygnature Discovery, Pharmaron Beijing Co., Ltd, WuXi Biologics (Cayman), Inc., Domainex Ltd., Thermo Fisher Scientific, Inc., Jubilant Biosys Ltd., Evotec SE, Eurofins Discovery,, GenScript Biotech Corporation, Asclepia MedChem Solutions, Asinex Ltd., AsisChem Inc., Aurelia Bioscience Ltd, Axxam SpA, Selcia Ltd, and Selvita S.A.

5. What is the study period of this market?
Ans: The Global Drug Discovery Outsourcing Market is studied from 2021 to 2029. 




Global Drug Discovery Outsourcing Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Drug Discovery Outsourcing Market Size, by Market Value (US$ Mn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global Drug Discovery Outsourcing Market Analysis and Forecast
6.1. Drug Discovery Outsourcing Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Drug Discovery Outsourcing Market Analysis and Forecast, By Drug Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Drug Discovery Outsourcing Market Value Share Analysis, By Drug Type
7.4. Drug Discovery Outsourcing Market Size (US$ Bn) Forecast, By Drug Type
7.5. Drug Discovery Outsourcing Market Analysis, By Drug Type
7.6. Drug Discovery Outsourcing Market Attractiveness Analysis, By Drug Type

8. Global Drug Discovery Outsourcing Market Analysis and Forecast, By Workflow
8.1. Introduction and Definition
8.2. Key Findings
8.3. Drug Discovery Outsourcing Market Value Share Analysis, By Workflow
8.4. Drug Discovery Outsourcing Market Size (US$ Bn) Forecast, By Workflow
8.5. Drug Discovery Outsourcing Market Analysis, By Workflow
8.6. Drug Discovery Outsourcing Market Attractiveness Analysis, By Workflow

9. Global Drug Discovery Outsourcing Market Analysis and Forecast, By Therapeutic Area
9.1. Introduction and Definition
9.2. Key Findings
9.3. Drug Discovery Outsourcing Market Value Share Analysis, By Therapeutic Area
9.4. Drug Discovery Outsourcing Market Size (US$ Bn) Forecast, By Therapeutic Area
9.5. Drug Discovery Outsourcing Market Analysis, By Therapeutic Area
9.6. Drug Discovery Outsourcing Market Attractiveness Analysis, By Therapeutic Area

10. Global Drug Discovery Outsourcing Market Analysis, by Region
10.1. Drug Discovery Outsourcing Market Value Share Analysis, by Region
10.2. Drug Discovery Outsourcing Market Size (US$ Bn) Forecast, by Region
10.3. Drug Discovery Outsourcing Market Attractiveness Analysis, by Region

11. North America Drug Discovery Outsourcing Market Analysis
11.1. Key Findings
11.2. North America Drug Discovery Outsourcing Market Overview
11.3. North America Drug Discovery Outsourcing Market Value Share Analysis, By Drug Type
11.4. North America Drug Discovery Outsourcing Market Forecast, By Drug Type
11.4.1. Small Molecules
11.4.2. Large Molecules (Biopharmaceuticals)
11.5. North America Drug Discovery Outsourcing Market Value Share Analysis, By Workflow
11.6. North America Drug Discovery Outsourcing Market Forecast, By Workflow
11.6.1. Target Identification & Screening
11.6.2. Target Validation & Functional Informatics
11.6.3. Lead Identification & Candidate Optimization
11.6.4. Preclinical Development
11.6.5. Other Associated Workflow
11.7. North America Drug Discovery Outsourcing Market Value Share Analysis, By Therapeutic Area
11.8. North America Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
11.8.1. Respiratory System
11.8.2. Pain and Anesthesia
11.8.3. Oncology
11.8.4. Ophthalmology
11.8.5. Hematology
11.8.6. Cardiovascular
11.8.7. Endocrine
11.8.8. Gastrointestinal
11.8.9. Immunomodulation
11.8.10. Anti-Infective
11.8.11. Central Nervous System
11.8.12. Dermatology
11.8.13. Genitourinary System
11.9. North America Drug Discovery Outsourcing Market Value Share Analysis, by Country
11.10. North America Drug Discovery Outsourcing Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Drug Discovery Outsourcing Market Analysis, by Country
11.12. U.S. Drug Discovery Outsourcing Market Forecast, By Drug Type
11.12.1. Small Molecules
11.12.2. Large Molecules (Biopharmaceuticals)
11.13. U.S. Drug Discovery Outsourcing Market Forecast, By Workflow
11.13.1. Target Identification & Screening
11.13.2. Target Validation & Functional Informatics
11.13.3. Lead Identification & Candidate Optimization
11.13.4. Preclinical Development
11.13.5. Other Associated Workflow
11.14. U.S. Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
11.14.1. Respiratory System
11.14.2. Pain and Anesthesia
11.14.3. Oncology
11.14.4. Ophthalmology
11.14.5. Hematology
11.14.6. Cardiovascular
11.14.7. Endocrine
11.14.8. Gastrointestinal
11.14.9. Immunomodulation
11.14.10. Anti-Infective
11.14.11. Central Nervous System
11.14.12. Dermatology
11.14.13. Genitourinary System
11.15. Canada Drug Discovery Outsourcing Market Forecast, By Drug Type
11.15.1. Small Molecules
11.15.2. Large Molecules (Biopharmaceuticals)
11.16. Canada Drug Discovery Outsourcing Market Forecast, By Workflow
11.16.1. Target Identification & Screening
11.16.2. Target Validation & Functional Informatics
11.16.3. Lead Identification & Candidate Optimization
11.16.4. Preclinical Development
11.16.5. Other Associated Workflow
11.17. Canada Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
11.17.1. Respiratory System
11.17.2. Pain and Anesthesia
11.17.3. Oncology
11.17.4. Ophthalmology
11.17.5. Hematology
11.17.6. Cardiovascular
11.17.7. Endocrine
11.17.8. Gastrointestinal
11.17.9. Immunomodulation
11.17.10. Anti-Infective
11.17.11. Central Nervous System
11.17.12. Dermatology
11.17.13. Genitourinary System
11.18. North America Drug Discovery Outsourcing Market Attractiveness Analysis
11.18.1. By Drug Type
11.18.2. By Workflow
11.18.3. By Therapeutic Area
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments

12. Europe Drug Discovery Outsourcing Market Analysis
12.1. Key Findings
12.2. Europe Drug Discovery Outsourcing Market Overview
12.3. Europe Drug Discovery Outsourcing Market Value Share Analysis, By Drug Type
12.4. Europe Drug Discovery Outsourcing Market Forecast, By Drug Type
12.4.1. Small Molecules
12.4.2. Large Molecules (Biopharmaceuticals)
12.5. Europe Drug Discovery Outsourcing Market Value Share Analysis, By Workflow
12.6. Europe Drug Discovery Outsourcing Market Forecast, By Workflow
12.6.1. Target Identification & Screening
12.6.2. Target Validation & Functional Informatics
12.6.3. Lead Identification & Candidate Optimization
12.6.4. Preclinical Development
12.6.5. Other Associated Workflow
12.7. Europe Drug Discovery Outsourcing Market Value Share Analysis, By Therapeutic Area
12.8. Europe Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
12.8.1. Respiratory System
12.8.2. Pain and Anesthesia
12.8.3. Oncology
12.8.4. Ophthalmology
12.8.5. Hematology
12.8.6. Cardiovascular
12.8.7. Endocrine
12.8.8. Gastrointestinal
12.8.9. Immunomodulation
12.8.10. Anti-Infective
12.8.11. Central Nervous System
12.8.12. Dermatology
12.8.13. Genitourinary System
12.9. Europe Drug Discovery Outsourcing Market Value Share Analysis, by Country
12.10. Europe Drug Discovery Outsourcing Market Forecast, by Country
12.10.1. Germany
12.10.2. UK
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Norway
12.10.7. Russia
12.11. Europe Drug Discovery Outsourcing Market Analysis, by Country
12.12. Germany Drug Discovery Outsourcing Market Forecast, By Drug Type
12.12.1. Small Molecules
12.12.2. Large Molecules (Biopharmaceuticals)
12.13. Germany Drug Discovery Outsourcing Market Forecast, By Workflow
12.13.1. Target Identification & Screening
12.13.2. Target Validation & Functional Informatics
12.13.3. Lead Identification & Candidate Optimization
12.13.4. Preclinical Development
12.13.5. Other Associated Workflow
12.14. Germany Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
12.14.1. Respiratory System
12.14.2. Pain and Anesthesia
12.14.3. Oncology
12.14.4. Ophthalmology
12.14.5. Hematology
12.14.6. Cardiovascular
12.14.7. Endocrine
12.14.8. Gastrointestinal
12.14.9. Immunomodulation
12.14.10. Anti-Infective
12.14.11. Central Nervous System
12.14.12. Dermatology
12.14.13. Genitourinary System
12.15. U.K. Drug Discovery Outsourcing Market Forecast, By Drug Type
12.15.1. Small Molecules
12.15.2. Large Molecules (Biopharmaceuticals)
12.16. U.K. Drug Discovery Outsourcing Market Forecast, By Workflow
12.16.1. Target Identification & Screening
12.16.2. Target Validation & Functional Informatics
12.16.3. Lead Identification & Candidate Optimization
12.16.4. Preclinical Development
12.16.5. Other Associated Workflow
12.17. U.K. Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
12.17.1. Respiratory System
12.17.2. Pain and Anesthesia
12.17.3. Oncology
12.17.4. Ophthalmology
12.17.5. Hematology
12.17.6. Cardiovascular
12.17.7. Endocrine
12.17.8. Gastrointestinal
12.17.9. Immunomodulation
12.17.10. Anti-Infective
12.17.11. Central Nervous System
12.17.12. Dermatology
12.17.13. Genitourinary System
12.18. France Drug Discovery Outsourcing Market Forecast, By Drug Type
12.18.1. Small Molecules
12.18.2. Large Molecules (Biopharmaceuticals)
12.19. France Drug Discovery Outsourcing Market Forecast, By Workflow
12.19.1. Target Identification & Screening
12.19.2. Target Validation & Functional Informatics
12.19.3. Lead Identification & Candidate Optimization
12.19.4. Preclinical Development
12.19.5. Other Associated Workflow
12.20. France Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
12.20.1. Respiratory System
12.20.2. Pain and Anesthesia
12.20.3. Oncology
12.20.4. Ophthalmology
12.20.5. Hematology
12.20.6. Cardiovascular
12.20.7. Endocrine
12.20.8. Gastrointestinal
12.20.9. Immunomodulation
12.20.10. Anti-Infective
12.20.11. Central Nervous System
12.20.12. Dermatology
12.20.13. Genitourinary System
12.21. Italy Drug Discovery Outsourcing Market Forecast, By Drug Type
12.21.1. Small Molecules
12.21.2. Large Molecules (Biopharmaceuticals)
12.22. Italy Drug Discovery Outsourcing Market Forecast, By Workflow
12.22.1. Target Identification & Screening
12.22.2. Target Validation & Functional Informatics
12.22.3. Lead Identification & Candidate Optimization
12.22.4. Preclinical Development
12.22.5. Other Associated Workflow
12.23. Italy Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
12.23.1. Respiratory System
12.23.2. Pain and Anesthesia
12.23.3. Oncology
12.23.4. Ophthalmology
12.23.5. Hematology
12.23.6. Cardiovascular
12.23.7. Endocrine
12.23.8. Gastrointestinal
12.23.9. Immunomodulation
12.23.10. Anti-Infective
12.23.11. Central Nervous System
12.23.12. Dermatology
12.23.13. Genitourinary System
12.24. Spain Drug Discovery Outsourcing Market Forecast, By Drug Type
12.24.1. Small Molecules
12.24.2. Large Molecules (Biopharmaceuticals)
12.25. Spain Drug Discovery Outsourcing Market Forecast, By Workflow
12.25.1. Target Identification & Screening
12.25.2. Target Validation & Functional Informatics
12.25.3. Lead Identification & Candidate Optimization
12.25.4. Preclinical Development
12.25.5. Other Associated Workflow
12.26. Spain Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
12.26.1. Respiratory System
12.26.2. Pain and Anesthesia
12.26.3. Oncology
12.26.4. Ophthalmology
12.26.5. Hematology
12.26.6. Cardiovascular
12.26.7. Endocrine
12.26.8. Gastrointestinal
12.26.9. Immunomodulation
12.26.10. Anti-Infective
12.26.11. Central Nervous System
12.26.12. Dermatology
12.26.13. Genitourinary System
12.27. Norway Drug Discovery Outsourcing Market Forecast, By Drug Type
12.27.1. Small Molecules
12.27.2. Large Molecules (Biopharmaceuticals)
12.28. Norway Drug Discovery Outsourcing Market Forecast, By Workflow
12.28.1. Target Identification & Screening
12.28.2. Target Validation & Functional Informatics
12.28.3. Lead Identification & Candidate Optimization
12.28.4. Preclinical Development
12.28.5. Other Associated Workflow
12.29. Norway Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
12.29.1. Respiratory System
12.29.2. Pain and Anesthesia
12.29.3. Oncology
12.29.4. Ophthalmology
12.29.5. Hematology
12.29.6. Cardiovascular
12.29.7. Endocrine
12.29.8. Gastrointestinal
12.29.9. Immunomodulation
12.29.10. Anti-Infective
12.29.11. Central Nervous System
12.29.12. Dermatology
12.29.13. Genitourinary System
12.30. Russia Drug Discovery Outsourcing Market Forecast, By Drug Type
12.30.1. Small Molecules
12.30.2. Large Molecules (Biopharmaceuticals)
12.31. Russia Drug Discovery Outsourcing Market Forecast, By Workflow
12.31.1. Target Identification & Screening
12.31.2. Target Validation & Functional Informatics
12.31.3. Lead Identification & Candidate Optimization
12.31.4. Preclinical Development
12.31.5. Other Associated Workflow
12.32. Russia Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
12.32.1. Respiratory System
12.32.2. Pain and Anesthesia
12.32.3. Oncology
12.32.4. Ophthalmology
12.32.5. Hematology
12.32.6. Cardiovascular
12.32.7. Endocrine
12.32.8. Gastrointestinal
12.32.9. Immunomodulation
12.32.10. Anti-Infective
12.32.11. Central Nervous System
12.32.12. Dermatology
12.32.13. Genitourinary System
12.33. Europe Drug Discovery Outsourcing Market Attractiveness Analysis
12.33.1. By Drug Type
12.33.2. By Workflow
12.33.3. By Therapeutic Area
12.34. PEST Analysis
12.35. Key Trends
12.36. Key Developments

13. Asia Pacific Drug Discovery Outsourcing Market Analysis
13.1. Key Findings
13.2. Asia Pacific Drug Discovery Outsourcing Market Overview
13.3. Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, By Drug Type
13.4. Asia Pacific Drug Discovery Outsourcing Market Forecast, By Drug Type
13.4.1. Small Molecules
13.4.2. Large Molecules (Biopharmaceuticals)
13.5. Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, By Workflow
13.6. Asia Pacific Drug Discovery Outsourcing Market Forecast, By Workflow
13.6.1. Target Identification & Screening
13.6.2. Target Validation & Functional Informatics
13.6.3. Lead Identification & Candidate Optimization
13.6.4. Preclinical Development
13.6.5. Other Associated Workflow
13.7. Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, By Therapeutic Area
13.8. Asia Pacific Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
13.8.1. Respiratory System
13.8.2. Pain and Anesthesia
13.8.3. Oncology
13.8.4. Ophthalmology
13.8.5. Hematology
13.8.6. Cardiovascular
13.8.7. Endocrine
13.8.8. Gastrointestinal
13.8.9. Immunomodulation
13.8.10. Anti-Infective
13.8.11. Central Nervous System
13.8.12. Dermatology
13.8.13. Genitourinary System
13.9. Asia Pacific Drug Discovery Outsourcing Market Value Share Analysis, by Country
13.10. Asia Pacific Drug Discovery Outsourcing Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. South Korea
13.10.5. Australia
13.10.6. Malaysia
13.10.7. Indonesia
13.10.8. Vietnam
13.11. Asia Pacific Drug Discovery Outsourcing Market Analysis, by Country
13.12. China Drug Discovery Outsourcing Market Forecast, By Drug Type
13.12.1. Small Molecules
13.12.2. Large Molecules (Biopharmaceuticals)
13.13. China Drug Discovery Outsourcing Market Forecast, By Workflow
13.13.1. Target Identification & Screening
13.13.2. Target Validation & Functional Informatics
13.13.3. Lead Identification & Candidate Optimization
13.13.4. Preclinical Development
13.13.5. Other Associated Workflow
13.14. China Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
13.14.1. Respiratory System
13.14.2. Pain and Anesthesia
13.14.3. Oncology
13.14.4. Ophthalmology
13.14.5. Hematology
13.14.6. Cardiovascular
13.14.7. Endocrine
13.14.8. Gastrointestinal
13.14.9. Immunomodulation
13.14.10. Anti-Infective
13.14.11. Central Nervous System
13.14.12. Dermatology
13.14.13. Genitourinary System
13.15. India Drug Discovery Outsourcing Market Forecast, By Drug Type
13.15.1. Small Molecules
13.15.2. Large Molecules (Biopharmaceuticals)
13.16. India Drug Discovery Outsourcing Market Forecast, By Workflow
13.16.1. Target Identification & Screening
13.16.2. Target Validation & Functional Informatics
13.16.3. Lead Identification & Candidate Optimization
13.16.4. Preclinical Development
13.16.5. Other Associated Workflow
13.17. India Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
13.17.1. Respiratory System
13.17.2. Pain and Anesthesia
13.17.3. Oncology
13.17.4. Ophthalmology
13.17.5. Hematology
13.17.6. Cardiovascular
13.17.7. Endocrine
13.17.8. Gastrointestinal
13.17.9. Immunomodulation
13.17.10. Anti-Infective
13.17.11. Central Nervous System
13.17.12. Dermatology
13.17.13. Genitourinary System
13.18. Japan Drug Discovery Outsourcing Market Forecast, By Drug Type
13.18.1. Small Molecules
13.18.2. Large Molecules (Biopharmaceuticals)
13.19. Japan Drug Discovery Outsourcing Market Forecast, By Workflow
13.19.1. Target Identification & Screening
13.19.2. Target Validation & Functional Informatics
13.19.3. Lead Identification & Candidate Optimization
13.19.4. Preclinical Development
13.19.5. Other Associated Workflow
13.20. Japan Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
13.20.1. Respiratory System
13.20.2. Pain and Anesthesia
13.20.3. Oncology
13.20.4. Ophthalmology
13.20.5. Hematology
13.20.6. Cardiovascular
13.20.7. Endocrine
13.20.8. Gastrointestinal
13.20.9. Immunomodulation
13.20.10. Anti-Infective
13.20.11. Central Nervous System
13.20.12. Dermatology
13.20.13. Genitourinary System
13.21. South Korea Drug Discovery Outsourcing Market Forecast, By Drug Type
13.21.1. Small Molecules
13.21.2. Large Molecules (Biopharmaceuticals)
13.22. South Korea Drug Discovery Outsourcing Market Forecast, By Workflow
13.22.1. Target Identification & Screening
13.22.2. Target Validation & Functional Informatics
13.22.3. Lead Identification & Candidate Optimization
13.22.4. Preclinical Development
13.22.5. Other Associated Workflow
13.23. South Korea Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
13.23.1. Respiratory System
13.23.2. Pain and Anesthesia
13.23.3. Oncology
13.23.4. Ophthalmology
13.23.5. Hematology
13.23.6. Cardiovascular
13.23.7. Endocrine
13.23.8. Gastrointestinal
13.23.9. Immunomodulation
13.23.10. Anti-Infective
13.23.11. Central Nervous System
13.23.12. Dermatology
13.23.13. Genitourinary System
13.24. Australia Drug Discovery Outsourcing Market Forecast, By Drug Type
13.24.1. Small Molecules
13.24.2. Large Molecules (Biopharmaceuticals)
13.25. Australia Drug Discovery Outsourcing Market Forecast, By Workflow
13.25.1. Target Identification & Screening
13.25.2. Target Validation & Functional Informatics
13.25.3. Lead Identification & Candidate Optimization
13.25.4. Preclinical Development
13.25.5. Other Associated Workflow
13.26. Australia Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
13.26.1. Respiratory System
13.26.2. Pain and Anesthesia
13.26.3. Oncology
13.26.4. Ophthalmology
13.26.5. Hematology
13.26.6. Cardiovascular
13.26.7. Endocrine
13.26.8. Gastrointestinal
13.26.9. Immunomodulation
13.26.10. Anti-Infective
13.26.11. Central Nervous System
13.26.12. Dermatology
13.26.13. Genitourinary System
13.27. Malaysia Drug Discovery Outsourcing Market Forecast, By Drug Type
13.27.1. Small Molecules
13.27.2. Large Molecules (Biopharmaceuticals)
13.28. Malaysia Drug Discovery Outsourcing Market Forecast, By Workflow
13.28.1. Target Identification & Screening
13.28.2. Target Validation & Functional Informatics
13.28.3. Lead Identification & Candidate Optimization
13.28.4. Preclinical Development
13.28.5. Other Associated Workflow
13.29. Malaysia Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
13.29.1. Respiratory System
13.29.2. Pain and Anesthesia
13.29.3. Oncology
13.29.4. Ophthalmology
13.29.5. Hematology
13.29.6. Cardiovascular
13.29.7. Endocrine
13.29.8. Gastrointestinal
13.29.9. Immunomodulation
13.29.10. Anti-Infective
13.29.11. Central Nervous System
13.29.12. Dermatology
13.29.13. Genitourinary System
13.30. Indonesia Drug Discovery Outsourcing Market Forecast, By Drug Type
13.30.1. Small Molecules
13.30.2. Large Molecules (Biopharmaceuticals)
13.31. Indonesia Drug Discovery Outsourcing Market Forecast, By Workflow
13.31.1. Target Identification & Screening
13.31.2. Target Validation & Functional Informatics
13.31.3. Lead Identification & Candidate Optimization
13.31.4. Preclinical Development
13.31.5. Other Associated Workflow
13.32. Indonesia Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
13.32.1. Respiratory System
13.32.2. Pain and Anesthesia
13.32.3. Oncology
13.32.4. Ophthalmology
13.32.5. Hematology
13.32.6. Cardiovascular
13.32.7. Endocrine
13.32.8. Gastrointestinal
13.32.9. Immunomodulation
13.32.10. Anti-Infective
13.32.11. Central Nervous System
13.32.12. Dermatology
13.32.13. Genitourinary System
13.33. Vietnam Drug Discovery Outsourcing Market Forecast, By Drug Type
13.33.1. Small Molecules
13.33.2. Large Molecules (Biopharmaceuticals)
13.34. Vietnam Drug Discovery Outsourcing Market Forecast, By Workflow
13.34.1. Target Identification & Screening
13.34.2. Target Validation & Functional Informatics
13.34.3. Lead Identification & Candidate Optimization
13.34.4. Preclinical Development
13.34.5. Other Associated Workflow
13.35. Vietnam Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
13.35.1. Respiratory System
13.35.2. Pain and Anesthesia
13.35.3. Oncology
13.35.4. Ophthalmology
13.35.5. Hematology
13.35.6. Cardiovascular
13.35.7. Endocrine
13.35.8. Gastrointestinal
13.35.9. Immunomodulation
13.35.10. Anti-Infective
13.35.11. Central Nervous System
13.35.12. Dermatology
13.35.13. Genitourinary System
13.36. Asia Pacific Drug Discovery Outsourcing Market Attractiveness Analysis
13.36.1. By Drug Type
13.36.2. By Workflow
13.36.3. By Therapeutic Area
13.37. PEST Analysis
13.38. Key Trends
13.39. Key Developments

14. Middle East & Africa Drug Discovery Outsourcing Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Drug Discovery Outsourcing Market Overview
14.3. Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, By Drug Type
14.4. Middle East & Africa Drug Discovery Outsourcing Market Forecast, By Drug Type
14.4.1. Small Molecules
14.4.2. Large Molecules (Biopharmaceuticals)
14.5. Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, By Workflow
14.6. Middle East & Africa Drug Discovery Outsourcing Market Forecast, By Workflow
14.6.1. Target Identification & Screening
14.6.2. Target Validation & Functional Informatics
14.6.3. Lead Identification & Candidate Optimization
14.6.4. Preclinical Development
14.6.5. Other Associated Workflow
14.7. Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, By Therapeutic Area
14.8. Middle East & Africa Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
14.8.1. Respiratory System
14.8.2. Pain and Anesthesia
14.8.3. Oncology
14.8.4. Ophthalmology
14.8.5. Hematology
14.8.6. Cardiovascular
14.8.7. Endocrine
14.8.8. Gastrointestinal
14.8.9. Immunomodulation
14.8.10. Anti-Infective
14.8.11. Central Nervous System
14.8.12. Dermatology
14.8.13. Genitourinary System
14.9. Middle East & Africa Drug Discovery Outsourcing Market Value Share Analysis, by Country
14.10. Middle East & Africa Drug Discovery Outsourcing Market Forecast, by Country
14.10.1. GCC Countries
14.10.2. South Africa
14.10.3. Nigeria
14.10.4. Egypt
14.11. Middle East & Africa Drug Discovery Outsourcing Market Analysis, by Country
14.12. GCC Drug Discovery Outsourcing Market Forecast, By Drug Type
14.12.1. Small Molecules
14.12.2. Large Molecules (Biopharmaceuticals)
14.13. GCC Drug Discovery Outsourcing Market Forecast, By Workflow
14.13.1. Target Identification & Screening
14.13.2. Target Validation & Functional Informatics
14.13.3. Lead Identification & Candidate Optimization
14.13.4. Preclinical Development
14.13.5. Other Associated Workflow
14.14. GCC Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
14.14.1. Respiratory System
14.14.2. Pain and Anesthesia
14.14.3. Oncology
14.14.4. Ophthalmology
14.14.5. Hematology
14.14.6. Cardiovascular
14.14.7. Endocrine
14.14.8. Gastrointestinal
14.14.9. Immunomodulation
14.14.10. Anti-Infective
14.14.11. Central Nervous System
14.14.12. Dermatology
14.14.13. Genitourinary System
14.15. South Africa Drug Discovery Outsourcing Market Forecast, By Drug Type
14.15.1. Small Molecules
14.15.2. Large Molecules (Biopharmaceuticals)
14.16. South Africa Drug Discovery Outsourcing Market Forecast, By Workflow
14.16.1. Target Identification & Screening
14.16.2. Target Validation & Functional Informatics
14.16.3. Lead Identification & Candidate Optimization
14.16.4. Preclinical Development
14.16.5. Other Associated Workflow
14.17. South Africa Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
14.17.1. Respiratory System
14.17.2. Pain and Anesthesia
14.17.3. Oncology
14.17.4. Ophthalmology
14.17.5. Hematology
14.17.6. Cardiovascular
14.17.7. Endocrine
14.17.8. Gastrointestinal
14.17.9. Immunomodulation
14.17.10. Anti-Infective
14.17.11. Central Nervous System
14.17.12. Dermatology
14.17.13. Genitourinary System
14.18. Nigeria Drug Discovery Outsourcing Market Forecast, By Drug Type
14.18.1. Small Molecules
14.18.2. Large Molecules (Biopharmaceuticals)
14.19. Nigeria Drug Discovery Outsourcing Market Forecast, By Workflow
14.19.1. Target Identification & Screening
14.19.2. Target Validation & Functional Informatics
14.19.3. Lead Identification & Candidate Optimization
14.19.4. Preclinical Development
14.19.5. Other Associated Workflow
14.20. Nigeria Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
14.20.1. Respiratory System
14.20.2. Pain and Anesthesia
14.20.3. Oncology
14.20.4. Ophthalmology
14.20.5. Hematology
14.20.6. Cardiovascular
14.20.7. Endocrine
14.20.8. Gastrointestinal
14.20.9. Immunomodulation
14.20.10. Anti-Infective
14.20.11. Central Nervous System
14.20.12. Dermatology
14.20.13. Genitourinary System
14.21. Egypt Drug Discovery Outsourcing Market Forecast, By Drug Type
14.21.1. Small Molecules
14.21.2. Large Molecules (Biopharmaceuticals)
14.22. Egypt Drug Discovery Outsourcing Market Forecast, By Workflow
14.22.1. Target Identification & Screening
14.22.2. Target Validation & Functional Informatics
14.22.3. Lead Identification & Candidate Optimization
14.22.4. Preclinical Development
14.22.5. Other Associated Workflow
14.23. Egypt Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
14.23.1. Respiratory System
14.23.2. Pain and Anesthesia
14.23.3. Oncology
14.23.4. Ophthalmology
14.23.5. Hematology
14.23.6. Cardiovascular
14.23.7. Endocrine
14.23.8. Gastrointestinal
14.23.9. Immunomodulation
14.23.10. Anti-Infective
14.23.11. Central Nervous System
14.23.12. Dermatology
14.23.13. Genitourinary System
14.24. Middle East & Africa Drug Discovery Outsourcing Market Attractiveness Analysis
14.24.1. By Drug Type
14.24.2. By Workflow
14.24.3. By Therapeutic Area
14.25. PEST Analysis
14.26. Key Trends
14.27. Key Developments

15. South America Drug Discovery Outsourcing Market Analysis
15.1. Key Findings
15.2. South America Drug Discovery Outsourcing Market Overview
15.3. South America Drug Discovery Outsourcing Market Value Share Analysis, By Drug Type
15.4. South America Drug Discovery Outsourcing Market Forecast, By Drug Type
15.4.1. Small Molecules
15.4.2. Large Molecules (Biopharmaceuticals)
15.5. South America Drug Discovery Outsourcing Market Value Share Analysis, By Workflow
15.6. South America Drug Discovery Outsourcing Market Forecast, By Workflow
15.6.1. Target Identification & Screening
15.6.2. Target Validation & Functional Informatics
15.6.3. Lead Identification & Candidate Optimization
15.6.4. Preclinical Development
15.6.5. Other Associated Workflow
15.7. South America Drug Discovery Outsourcing Market Value Share Analysis, By Therapeutic Area
15.8. South America Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
15.8.1. Respiratory System
15.8.2. Pain and Anesthesia
15.8.3. Oncology
15.8.4. Ophthalmology
15.8.5. Hematology
15.8.6. Cardiovascular
15.8.7. Endocrine
15.8.8. Gastrointestinal
15.8.9. Immunomodulation
15.8.10. Anti-Infective
15.8.11. Central Nervous System
15.8.12. Dermatology
15.8.13. Genitourinary System
15.9. South America Drug Discovery Outsourcing Market Value Share Analysis, by Country
15.10. South America Drug Discovery Outsourcing Market Forecast, by Country
15.10.1. Mexico
15.10.2. Brazil
15.10.3. Argentina
15.11. South America Drug Discovery Outsourcing Market Analysis, by Country
15.12. Brazil Drug Discovery Outsourcing Market Forecast, By Drug Type
15.12.1. Small Molecules
15.12.2. Large Molecules (Biopharmaceuticals)
15.13. Brazil Drug Discovery Outsourcing Market Forecast, By Workflow
15.13.1. Target Identification & Screening
15.13.2. Target Validation & Functional Informatics
15.13.3. Lead Identification & Candidate Optimization
15.13.4. Preclinical Development
15.13.5. Other Associated Workflow
15.14. Brazil Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
15.14.1. Respiratory System
15.14.2. Pain and Anesthesia
15.14.3. Oncology
15.14.4. Ophthalmology
15.14.5. Hematology
15.14.6. Cardiovascular
15.14.7. Endocrine
15.14.8. Gastrointestinal
15.14.9. Immunomodulation
15.14.10. Anti-Infective
15.14.11. Central Nervous System
15.14.12. Dermatology
15.14.13. Genitourinary System
15.15. Mexico Drug Discovery Outsourcing Market Forecast, By Drug Type
15.15.1. Small Molecules
15.15.2. Large Molecules (Biopharmaceuticals)
15.16. Mexico Drug Discovery Outsourcing Market Forecast, By Workflow
15.16.1. Target Identification & Screening
15.16.2. Target Validation & Functional Informatics
15.16.3. Lead Identification & Candidate Optimization
15.16.4. Preclinical Development
15.16.5. Other Associated Workflow
15.17. Mexico Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
15.17.1. Respiratory System
15.17.2. Pain and Anesthesia
15.17.3. Oncology
15.17.4. Ophthalmology
15.17.5. Hematology
15.17.6. Cardiovascular
15.17.7. Endocrine
15.17.8. Gastrointestinal
15.17.9. Immunomodulation
15.17.10. Anti-Infective
15.17.11. Central Nervous System
15.17.12. Dermatology
15.17.13. Genitourinary System
15.18. Argentina Drug Discovery Outsourcing Market Forecast, By Drug Type
15.18.1. Small Molecules
15.18.2. Large Molecules (Biopharmaceuticals)
15.19. Argentina Drug Discovery Outsourcing Market Forecast, By Workflow
15.19.1. Target Identification & Screening
15.19.2. Target Validation & Functional Informatics
15.19.3. Lead Identification & Candidate Optimization
15.19.4. Preclinical Development
15.19.5. Other Associated Workflow
15.20. Argentina Drug Discovery Outsourcing Market Forecast, By Therapeutic Area
15.20.1. Respiratory System
15.20.2. Pain and Anesthesia
15.20.3. Oncology
15.20.4. Ophthalmology
15.20.5. Hematology
15.20.6. Cardiovascular
15.20.7. Endocrine
15.20.8. Gastrointestinal
15.20.9. Immunomodulation
15.20.10. Anti-Infective
15.20.11. Central Nervous System
15.20.12. Dermatology
15.20.13. Genitourinary System
15.21. South America Drug Discovery Outsourcing Market Attractiveness Analysis
15.21.1. By Drug Type
15.21.2. By Workflow
15.21.3. By Therapeutic Area
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments

16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward Integration
16.3. Company Profiles: Key Players
16.3.1. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. WuXi AppTec Co., Ltd.
16.3.3. Albany Molecular Research Inc. (AMRI)
16.3.4. GVK Biosciences Private Limited
16.3.5. Sygnature Discovery
16.3.6. Pharmaron Beijing Co., Ltd
16.3.7. WuXi Biologics (Cayman), Inc.
16.3.8. Domainex Ltd.
16.3.9. Thermo Fisher Scientific, Inc.
16.3.10. Jubilant Biosys Ltd.
16.3.11. Evotec SE
16.3.12. Eurofins Discovery,
16.3.13. GenScript Biotech Corporation
16.3.14. Asclepia MedChem Solutions
16.3.15. Asinex Ltd.
16.3.16. AsisChem Inc.
16.3.17. Aurelia Bioscience Ltd
16.3.18. Axxam SpA
16.3.19. Selcia Ltd
16.3.20. Selvita S.A.
17. Primary Key Insights
  • INQUIRE BEFORE BUYING